[an error occurred while processing the directive]
RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Evotek-Miray Genomiks (EMG)

Company

Content

Owners

History

2020: Attraction of 0.5 billion rubles of the Russian-Japanese investment fund

On May 6, 2020 it became known of attraction of investments by Evotek-Miray Genomiks company from the Russian-Japanese investment fund (RYaIF, RDIF, Japan Bank for International Cooperation and JBIC IG Partners is created). The amount of investments was 500 million rubles.

It is noted that joint efforts of RDIF and RYaIF within this project were earlier supported by the Ministry of Economic Development of the Russian Federation and the Ministry of Economics, trade and the industry of Japan.

The Russian-Japanese investment fund invests in the producer of tests for a coronavirus of EMG
File:Aquote1.png
Investments of RYaIF will allow EMG to expand production and to continue work on creation of more perfect diagnostic systems. It will give the chance to increase volumes of testing and to interfere with spread of a virus — the head of RDIF Kirill Dmitriyev noted.
File:Aquote2.png

Before RDIF already invested in production and distribution of a diagnostic system of EMG.

RDIF also reported that diagnostic systems of EMG got permission to use in France. The first client of the company in the country — Orange Marine, division of the French telecommunication holding Orange. 

MSE Group, the partner company of EMG representing its interests in Europe officially began to render assistance to the largest companies of France in testing of employees in May, 2020. MSE Group is going to provide delivery to 100 mobile laboratories and to carry out 500,000 tests in France within the next two months.

By May 7 MSE Group conducts negotiations with the companies from the pharmaceutical sector and services industry (the service connected on a visit the employees home to clients) and also with laboratories for expansion of scales of testing in France.

Orders for more than 2 million EMG tests already placed 40 largest Russian companies. Production of tests is performed in the territory of the Russian Federation. Global demand for the EMG tests exceeds 20 million units by May, 2020. [1]

Notes

  1. [The Russian-Japanese investment fund invests in the producer of tests for EMG https://rdif.ru/fullNews/5104/ coronavirus]